Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
BMC Cancer
2018 Nov 12;181:1090. doi: 10.1186/s12885-018-5030-1.
Show Gene links
Show Anatomy links
Porphyrins are increased in the faeces of patients with prostate cancer: a case-control study.
Gotardelo DR
,
Courrol LC
,
Bellini MH
,
de Oliveira Silva FR
,
Soares CRJ
.
???displayArticle.abstract???
BACKGROUND: Experimental models of prostate cancer have demonstrated increased levels of protoporphyrin IX (PpIX) in the blood and faeces of mice. Hence, the quantification of these autofluorescent molecules could be hypothesized to be a potential marker for this type of tumour. In this case-control study, the autofluorescence of porphyrins in human faeces from patients with prostate cancer and control subjects was analysed using fluorescence spectroscopy.
METHODS: First, 3 mL of analytical-grade acetone was added to 0.3 g of faeces, and the mixture was macerated and centrifuged at 4000 rpm for 15 min. The supernatant was analysed spectroscopically. The emission spectra from 550 to 750 nm were obtained by exciting the samples at 405 nm.
RESULTS: A significant difference between the samples from control and cancer subjects was established in the spectral region of 670-675 nm (p = 0.000127), which corresponds to a significant increase in faecal porphyrins in patients with cancer. There was no statistically significant correlation between PSA levels and faecal porphyrins.
CONCLUSION: In this preliminary study conducted in humans, the results show a simple and non-invasive method to assess faecal porphyrins, which have the potential to function as a tumour biomarker in patients with prostate cancer. This approach has improved sensitivity and specificity over PSA testing. Additional prospective studies with larger sample sizes are required to validate these findings.
Bellini,
Correlation between autofluorescence intensity and tumor area in mice bearing renal cell carcinoma.
2008, Pubmed
Bellini,
Correlation between autofluorescence intensity and tumor area in mice bearing renal cell carcinoma.
2008,
Pubmed
Beukeveld,
Patterns of porphyrin excretion in feces as determined by liquid chromatography; reference values and the effect of flora suppression.
1987,
Pubmed
Camaschella,
Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
2009,
Pubmed
Fitzmaurice,
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.
2017,
Pubmed
Hernandez,
Contemporary evaluation of the D'amico risk classification of prostate cancer.
2007,
Pubmed
Hindmarsh,
Biochemical differentiation of the porphyrias.
1999,
Pubmed
Hyun,
A preliminary study of protoporphyrin-IX as a potential candidate for identification of lung cancer cells using fluorescence microscopy.
2009,
Pubmed
Jia,
Concentration of protoporphyrin IX in cancer tissues and blood in patients with colorectal cancer at early stage.
2009,
Pubmed
Kalaivani,
Fluorescence spectra of blood components for breast cancer diagnosis.
2008,
Pubmed
McNaughton Collins,
Early detection of prostate cancer. Serendipity strikes again.
1997,
Pubmed
Moesta,
Protoporphyrin IX occurs naturally in colorectal cancers and their metastases.
2001,
Pubmed
Nakayama,
Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy.
2016,
Pubmed
Nascimento da Silva,
Liquid biopsy of atherosclerosis using protoporphyrin IX as a biomarker.
2014,
Pubmed
,
Echinobase
Obort,
Prostate-specific antigen: any successor in sight?
2013,
Pubmed
Punglia,
Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.
2003,
Pubmed
Risk,
New and novel markers for prostate cancer detection.
2009,
Pubmed
Silva,
Study of protoporphyrin IX elimination by body excreta: a new noninvasive cancer diagnostic method?
2013,
Pubmed
Tosoian,
Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
2017,
Pubmed
de Oliveira Silva,
Intrinsic fluorescence of protoporphyrin IX from blood samples can yield information on the growth of prostate tumours.
2010,
Pubmed
el-Sharabasy,
Porphyrin metabolism in some malignant diseases.
1992,
Pubmed
